29 April 2017
News and Views
Links and Services
The latest issue of Helicobacter reports that long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia after H. pylori eradication.
Intestinal metaplasia has overexpressions of COX-2.
Short-term 8-week celecoxib, a selecti
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors